Insider transactions

EDGAR

Imunon, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
6 transactions, 22,385 shares
Sum of shares × price per share: 38,153.0213

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 74

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-06 Filed 2026-11-10Dentzer James E Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)13,1660.845
11,125.27

Derived: shares × price per share. Exact value 11125.270.

34,197Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of board fees
Open filing 0001437749-26-036264 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Lindborg Stacy Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)3,8040.845
3,214.38

Derived: shares × price per share. Exact value 3214.380.

122,581Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-036259 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Braun Donald P Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)11,7460.845
9,925.37

Derived: shares × price per share. Exact value 9925.370.

33,643Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of board fees
Open filing 0001437749-26-036265 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Fritz Frederick J. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)13.1660.845
11.12527

Derived: shares × price per share. Exact value 11.125270.

28,242Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of board fees.
Open filing 0001437749-26-036262 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Tardugno Michael H Director · Officer: Executive Chairman of Board
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)9,9690.845
8,423.805

Derived: shares × price per share. Exact value 8423.805.

128,511Direct (D) No
F1
  • F1 Stock granted in lieu of cash for base salary
Open filing 0001437749-26-036258 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Faller Douglas Vincent Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)1,5960.845
1,348.62

Derived: shares × price per share. Exact value 1348.620.

76,356Direct (D) No— Open filing 0001437749-26-036261 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Pellizzari Christine A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)13,1660.845
11,125.27

Derived: shares × price per share. Exact value 11125.270.

28,665Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of board fees
Open filing 0001437749-26-036263 Read from the filing’s XML Dispute this row
2026-10-23 Filed 2026-10-27Faller Douglas Vincent Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)26,7411.235
33,025.135

Derived: shares × price per share. Exact value 33025.135.

74,760Direct (D) No— Open filing 0001437749-26-033644 Read from the filing’s XML Dispute this row
2026-10-23 Filed 2026-10-27Faller Douglas Vincent Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)1,0921.235
1,348.62

Derived: shares × price per share. Exact value 1348.620.

48,019Direct (D) No— Open filing 0001437749-26-033644 Read from the filing’s XML Dispute this row
2026-10-23 Filed 2026-10-27Lindborg Stacy Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2,6031.235
3,214.705

Derived: shares × price per share. Exact value 3214.705.

118,777Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-033647 Read from the filing’s XML Dispute this row
2026-10-23 Filed 2026-10-27Tardugno Michael H Director · Officer: Executive Chairman of Board
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)6,8211.235
8,423.935

Derived: shares × price per share. Exact value 8423.935.

118,542Direct (D) No
F1
  • F1 Stock granted in lieu of cash for base salary
Open filing 0001437749-26-033649 Read from the filing’s XML Dispute this row
2026-10-09 Filed 2026-10-13Tardugno Michael H Director · Officer: Executive Chairman of Board
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)7,8001.08
8,424

Derived: shares × price per share. Exact value 8424.00.

111,721Direct (D) No
F1
  • F1 Stock granted in lieu of cash for base salary
Open filing 0001437749-26-032563 Read from the filing’s XML Dispute this row
2026-10-09 Filed 2026-10-13Faller Douglas Vincent Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)1,2491.08
1,348.92

Derived: shares × price per share. Exact value 1348.92.

46,927Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-032560 Read from the filing’s XML Dispute this row
2026-10-09 Filed 2026-10-13Lindborg Stacy Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2,9771.08
3,215.16

Derived: shares × price per share. Exact value 3215.16.

116,174Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-032562 Read from the filing’s XML Dispute this row
2026-09-25 Filed 2026-09-28Tardugno Michael H Director · Officer: Executive Chairman of Board
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)7,1691.41
10,108.29

Derived: shares × price per share. Exact value 10108.29.

103,921Direct (D) No
F1
  • F1 Stock granted in lieu of cash for base salary
Open filing 0001437749-26-031363 Read from the filing’s XML Dispute this row
2026-09-25 Filed 2026-09-28Faller Douglas Vincent Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,3901.41
6,189.9

Derived: shares × price per share. Exact value 6189.90.

45,678Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-031360 Read from the filing’s XML Dispute this row
2026-09-25 Filed 2026-09-28Lindborg Stacy Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)6,6971.41
9,442.77

Derived: shares × price per share. Exact value 9442.77.

113,197Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-031362 Read from the filing’s XML Dispute this row
2026-09-11 Filed 2026-09-15Lindborg Stacy Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,5041.47
8,090.88

Derived: shares × price per share. Exact value 8090.88.

105,580Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-030414 Read from the filing’s XML Dispute this row
2026-09-11 Filed 2026-09-15Tardugno Michael H Director · Officer: Executive Chairman of Board
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,8241.47
8,561.28

Derived: shares × price per share. Exact value 8561.28.

95,699Direct (D) No
F1
  • F1 Stock granted in lieu of cash for base salary
Open filing 0001437749-26-030415 Read from the filing’s XML Dispute this row
2026-09-11 Filed 2026-09-15Faller Douglas Vincent Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,2111.47
6,190.17

Derived: shares × price per share. Exact value 6190.17.

41,288Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-030413 Read from the filing’s XML Dispute this row
2026-08-31 Filed 2026-09-01Eylward Susan Officer: General Counsel and Corp Sec
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,5251.5643
3,949.8575

Derived: shares × price per share. Exact value 3949.8575.

2,896Direct (D) No
F2
  • F2 Reflects a weighted average sale price of $1.5643 per share, at prices ranging from $1.55 to $1.58 per share. The reporting person will provide, upon request by the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price.
Open filing 0001437749-26-029405 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-09-01Lindborg Stacy Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)6,8221.60
10,915.2

Derived: shares × price per share. Exact value 10915.20.

100,076Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-029408 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-09-01Eylward Susan Officer: General Counsel and Corp Sec
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2,5251.60
4,040

Derived: shares × price per share. Exact value 4040.00.

5,421Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-029405 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-09-01Faller Douglas Vincent Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)3,6261.60
5,801.6

Derived: shares × price per share. Exact value 5801.60.

37,077Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-029407 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-09-01Tardugno Michael H Director · Officer: Executive Chairman of Board
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)7,3711.60
11,793.6

Derived: shares × price per share. Exact value 11793.60.

89,875Direct (D) No
F1
  • F1 Stock granted in lieu of cash for base salary
Open filing 0001437749-26-029409 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-17Eylward Susan Officer: General Counsel and Corp Sec
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,4491.6303
3,992.6047

Derived: shares × price per share. Exact value 3992.6047.

2,896Direct (D) No
F2
  • F2 Reflects a weighted average sale price of $1.6303 per share, at prices ranging from $1.61 to $1.655 per share. The reporting person will provide, upon request by the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price.
Open filing 0001437749-26-028184 Read from the filing’s XML Dispute this row
2026-08-14 Filed 2026-08-17Faller Douglas Vincent Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)3,5161.65
5,801.4

Derived: shares × price per share. Exact value 5801.40.

33,451Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-028186 Read from the filing’s XML Dispute this row
2026-08-14 Filed 2026-08-17Tardugno Michael H Director · Officer: Executive Chairman of Board
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)7,1471.65
11,792.55

Derived: shares × price per share. Exact value 11792.55.

82,504Direct (D) No
F1
  • F1 Stock granted in lieu of cash for base salary
Open filing 0001437749-26-028185 Read from the filing’s XML Dispute this row
2026-08-14 Filed 2026-08-17Lindborg Stacy Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)6,6151.65
10,914.75

Derived: shares × price per share. Exact value 10914.75.

93,254Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-028187 Read from the filing’s XML Dispute this row
2026-08-14 Filed 2026-08-17Eylward Susan Officer: General Counsel and Corp Sec
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2,4491.65
4,040.85

Derived: shares × price per share. Exact value 4040.85.

5,345Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-028184 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-04Eylward Susan Officer: General Counsel and Corp Sec
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,5411.5651
3,976.9191

Derived: shares × price per share. Exact value 3976.9191.

2,896Direct (D) No
F2
  • F2 Reflects a weighted average sale price of $1.5651 per share, at prices ranging from $1.56 to $1.575 per share. The reporting person will provide, upon request by the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price.
Open filing 0001437749-26-025661 Read from the filing’s XML Dispute this row
2026-07-31 Filed 2026-08-04Faller Douglas Vincent Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)3,6491.59
5,801.91

Derived: shares × price per share. Exact value 5801.91.

29,935Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-025658 Read from the filing’s XML Dispute this row
2026-07-31 Filed 2026-08-04Pellizzari Christine A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)6,9341.59
11,025.06

Derived: shares × price per share. Exact value 11025.06.

15,076Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of board fees
Open filing 0001437749-26-025671 Read from the filing’s XML Dispute this row
2026-07-31 Filed 2026-08-04Tardugno Michael H Director · Officer: Executive Chairman of Board
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)6,3581.59
10,109.22

Derived: shares × price per share. Exact value 10109.22.

75,357Direct (D) No
F1
  • F1 Stock granted in lieu of cash for base salary
Open filing 0001437749-26-025660 Read from the filing’s XML Dispute this row
2026-07-31 Filed 2026-08-04Fritz Frederick J. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)6,9341.59
11,025.06

Derived: shares × price per share. Exact value 11025.06.

21,031Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of board fees.
Open filing 0001437749-26-025665 Read from the filing’s XML Dispute this row
2026-07-31 Filed 2026-08-04Eylward Susan Officer: General Counsel and Corp Sec
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2,5411.59
4,040.19

Derived: shares × price per share. Exact value 4040.19.

5,437Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-025661 Read from the filing’s XML Dispute this row
2026-07-31 Filed 2026-08-04Braun Donald P Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)6,1801.59
9,826.2

Derived: shares × price per share. Exact value 9826.20.

15,499Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of board fees
Open filing 0001437749-26-025663 Read from the filing’s XML Dispute this row
2026-07-31 Filed 2026-08-04Dentzer James E Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)6,9341.59
11,025.06

Derived: shares × price per share. Exact value 11025.06.

21,897Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of board fees
Open filing 0001437749-26-025667 Read from the filing’s XML Dispute this row
2026-07-31 Filed 2026-08-04Lindborg Stacy Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,0101.59
7,965.9

Derived: shares × price per share. Exact value 7965.90.

86,639Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-025655 Read from the filing’s XML Dispute this row
2026-07-20 Filed 2026-07-21Eylward Susan Officer: General Counsel and Corp Sec
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,1501.7816
3,830.44

Derived: shares × price per share. Exact value 3830.4400.

2,896Direct (D) No
F2
  • F2 Reflects a weighted average sale price of $1.7816 per share, at prices ranging from $1.76 to $1.79 per share. The reporting person will provide, upon request by the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price.
Open filing 0001437749-26-023948 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-21Faller Douglas Vincent Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)3,0821.83
5,640.06

Derived: shares × price per share. Exact value 5640.06.

26,286Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-023947 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-21Lindborg Stacy Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,9071.83
8,979.81

Derived: shares × price per share. Exact value 8979.81.

81,629Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-023946 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-21Tardugno Michael H Director · Officer: Executive Chairman of Board
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,6031.83
8,423.49

Derived: shares × price per share. Exact value 8423.49.

68,999Direct (D) No
F1
  • F1 Stock granted in lieu of cash for base salary
Open filing 0001437749-26-023949 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-21Eylward Susan Officer: General Counsel and Corp Sec
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2,1501.83
3,934.5

Derived: shares × price per share. Exact value 3934.50.

5,046Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-023948 Read from the filing’s XML Dispute this row
2026-07-06 Filed 2026-07-07Eylward Susan Officer: General Counsel and Corp Sec
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)9201.88
1,729.6

Derived: shares × price per share. Exact value 1729.60.

2,896Direct (D) No— Open filing 0001437749-26-022944 Read from the filing’s XML Dispute this row
2026-07-02 Filed 2026-07-07Lindborg Stacy Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2,5341.91
4,839.94

Derived: shares × price per share. Exact value 4839.94.

76,722Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-022941 Read from the filing’s XML Dispute this row
2026-07-02 Filed 2026-07-07Faller Douglas Vincent Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)1,3081.91
2,498.28

Derived: shares × price per share. Exact value 2498.28.

23,204Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-022943 Read from the filing’s XML Dispute this row
2026-07-02 Filed 2026-07-07Tardugno Michael H Director · Officer: Executive Chairman of Board
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,4101.91
8,423.1

Derived: shares × price per share. Exact value 8423.10.

64,396Direct (D) No
F1
  • F1 Stock granted in lieu of cash for base salary
Open filing 0001437749-26-022948 Read from the filing’s XML Dispute this row
2026-07-02 Filed 2026-07-07Eylward Susan Officer: General Counsel and Corp Sec
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)9201.91
1,757.2

Derived: shares × price per share. Exact value 1757.20.

3,816Direct (D) No
F1
  • F1 Stock granted in lieu of cash for portion of base salary
Open filing 0001437749-26-022944 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-06-29Eylward Susan Officer: General Counsel and Corp Sec
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)11,8001.752
20,673.6

Derived: shares × price per share. Exact value 20673.600.

2,896Direct (D) No
F2
  • F2 Reflects a weighted average sale price of $1.752 per share, at prices ranging from $1.73 to $1.80 per share. The reporting person will provide, upon request by the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price.
Open filing 0001437749-26-022008 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.

Showing 1–22 of 22

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
ARMISTICE CAPITAL, LLC 270,497 SH348,941 dollarsHigher by 125,730 Prior quarter: 144,767Open filing 0001315863-26-000784 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 46,967 SH60,587 dollarsUnchanged Prior quarter: 46,967Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager41,104 SH53,026 dollarsHigher by 9,475 Prior quarter: 31,629Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
Nvest Financial, LLC 26,286 SH33,909 dollarsNot in the prior quarter’s filings read Open filing 0001951757-26-001895 Filed 2026-11-12 Dispute this row
STATE STREET CORP Partly reported under another manager15,831 SH20,422 dollarsNot in the prior quarter’s filings read Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
VANGUARD FIDUCIARY TRUST CO 13,269 SH17,117 dollarsUnchanged Prior quarter: 13,269Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
HRT FINANCIAL LP 11,697 SH15 dollarsNot in the prior quarter’s filings read Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager10,342 SH13,341 dollarsUnchanged Prior quarter: 10,342Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
Tower Research Capital LLC (TRC) Partly reported under another manager5,596 SH7,219 dollarsHigher by 1,644 Prior quarter: 3,952Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager4,464 SH5,759 dollarsUnchanged Prior quarter: 4,464Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
WELLS FARGO COMPANY/MN Partly reported under another manager3,285 SH4,238 dollarsLower by 57 Prior quarter: 3,342Open filing 0000072971-26-000342 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager2,027 SH2,615 dollarsLower by 3,176 Prior quarter: 5,203Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
MORGAN STANLEY Partly reported under another manager1,503 SH1,940 dollarsLower by 71 Prior quarter: 1,574Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
SBI Securities Co., Ltd. 1,027 SH1,325 dollarsUnchanged Prior quarter: 1,027Open filing 0001851815-26-000004 Filed 2026-10-22 Dispute this row
CITIGROUP INC Partly reported under another manager922 SH1,189 dollarsNot in the prior quarter’s filings read Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row
GROUP ONE TRADING LLC 6 SH8 dollarsUnchanged Prior quarter: 6Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row
OSAIC HOLDINGS, INC. Partly reported under another manager3 SH3 dollarsHigher by 1 Prior quarter: 2Open filing 0001677044-26-000011 Filed 2026-11-12 Dispute this row
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 2 SH3 dollarsLower by 1 Prior quarter: 3Open filing 0001085146-26-000940 Filed 2026-11-13 Dispute this row
Steigerwald, Gordon Koch Inc. 1 SH1 dollarsUnchanged Prior quarter: 1Open filing 0001731876-26-000009 Filed 2026-11-12 Dispute this row
GK Wealth Management LLC 1 SH1 dollarsNot in the prior quarter’s filings read Open filing 0002069222-26-000005 Filed 2026-10-09 Dispute this row
ROYAL BANK OF CANADA Partly reported under another manager1 SH0 dollarsUnchanged Prior quarter: 1Open filing 0001140361-26-044123 Filed 2026-11-16 Dispute this row
Game Plan Financial Advisors, LLC 1 SH1 dollarsUnchanged Prior quarter: 1Open filing 0001802952-26-000004 Filed 2026-11-10 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Riverview Capital Advisers, LLC 34,364 SH
  • Virtu Financial LLC 17,456 SH
  • BARCLAYS PLC 194 SH
  • JPMORGAN CHASE CO 134 SH
  • Caitong International Asset Management Co., Ltd 8 SH
  • MERCER GLOBAL ADVISORS INC /ADV 1 SH
  • FMR LLC 1 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

Showing 1–4 of 4

House members’ trades in this company, newest report first, as filed
MemberTransaction dateTypeAmountOwnerReport
Hon. Roger W. Marshall (KS01)2017-06-05Purchase$1,001 - $15,000DC2018-08-06
Hon. Roger W. Marshall (KS01)2017-06-05Sale$1,001 - $15,000DC2018-08-06
Hon. Roger W. Marshall (KS01)2017-06-16Purchase$1,001 - $15,000DC2018-08-06
Hon. Roger W. Marshall (KS01)2017-06-16Sale$1,001 - $15,000DC2018-08-06

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Armistice Capital, LLC Common stock, par value $0.01 per share4.99280,508.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 3Open filing 0001172661-26-005233 Dispute this row
Steven Boyd Common stock, par value $0.01 per share4.99280,508.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 3Open filing 0001172661-26-005233 Dispute this row
Armistice Capital, LLC Common stock, par value $0.01 per share9.99450,315.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 2Open filing 0001172661-26-003591 Dispute this row
Steven Boyd Common stock, par value $0.01 per share9.99450,315.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 2Open filing 0001172661-26-003591 Dispute this row
Armistice Capital, LLC Common stock, par value $0.01 per share9.99396,718.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-002157 Dispute this row
Steven Boyd Common stock, par value $0.01 per share9.99396,718.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-002157 Dispute this row
Armistice Capital, LLC Common stock, par value $0.01 per share9.99349,917.0012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0001172661-26-001255 Dispute this row
Steven Boyd Common stock, par value $0.01 per share9.99349,917.0012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0001172661-26-001255 Dispute this row
Ayrton Capital LLC Common stock, par value $0.01 per share0.02,000.0006/30/2025 Filed 2025-08-13SCHEDULE 13G/AAmendment 2Open filing 0001641172-25-023310 Dispute this row
Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B Common stock, par value $0.01 per share0.02,000.0006/30/2025 Filed 2025-08-13SCHEDULE 13G/AAmendment 2Open filing 0001641172-25-023310 Dispute this row
Waqas Khatri Common stock, par value $0.01 per share0.02,000.0006/30/2025 Filed 2025-08-13SCHEDULE 13G/AAmendment 2Open filing 0001641172-25-023310 Dispute this row
Mitchell P. Kopin Common stock, par value $0.01 per share4.991,067,196.0006/30/2025 Filed 2025-08-12SCHEDULE 13G/AAmendment 1Open filing 0001213900-25-075077 Dispute this row
Daniel B. Asher Common stock, par value $0.01 per share4.991,067,196.0006/30/2025 Filed 2025-08-12SCHEDULE 13G/AAmendment 1Open filing 0001213900-25-075077 Dispute this row
Intracoastal Capital LLC Common stock, par value $0.01 per share4.991,067,196.0006/30/2025 Filed 2025-08-12SCHEDULE 13G/AAmendment 1Open filing 0001213900-25-075077 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,592,621 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020218,850
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026262,467

Filings made before the SEC required XML are listed, not extracted.

Back to Imunon, Inc.